Abstract
Repulsive guidance molecules (RGMs) are a group of glycosylphosphatidylinositol (GPI)-linked cellmembrane- associated proteins recently described. RGM family members play a diverse role in axonal guidance during embryo development, neuronal cell adhesion and regulation of systemic iron metabolism. Another important role of the RGM family, discovered recently, is that they act as co-receptors of bone morphogenetic proteins (BMPs), a group of proteins that are involved in bone development and the differentiation and progression of cancer. This indicates the potential impact of RGMs on cancer. The current review discusses the present knowledge on RGMs, their roles in BMP signalling and their potential implication in development and progression of cancer, particularly in the BMPs related bone metastasis.
Keywords: Repulsive guidance molecules (RGM), Neogenin, BMP signalling pathway, Smad, Cancer
Current Signal Transduction Therapy
Title:Repulsive Guidance Molecules (RGMs) and Their Potential Implication in Cancer as Co-receptor of BMPs
Volume: 7 Issue: 2
Author(s): Jin Li, Lin Ye and Wen G. Jiang
Affiliation:
Keywords: Repulsive guidance molecules (RGM), Neogenin, BMP signalling pathway, Smad, Cancer
Abstract: Repulsive guidance molecules (RGMs) are a group of glycosylphosphatidylinositol (GPI)-linked cellmembrane- associated proteins recently described. RGM family members play a diverse role in axonal guidance during embryo development, neuronal cell adhesion and regulation of systemic iron metabolism. Another important role of the RGM family, discovered recently, is that they act as co-receptors of bone morphogenetic proteins (BMPs), a group of proteins that are involved in bone development and the differentiation and progression of cancer. This indicates the potential impact of RGMs on cancer. The current review discusses the present knowledge on RGMs, their roles in BMP signalling and their potential implication in development and progression of cancer, particularly in the BMPs related bone metastasis.
Export Options
About this article
Cite this article as:
Li Jin, Ye Lin and G. Jiang Wen, Repulsive Guidance Molecules (RGMs) and Their Potential Implication in Cancer as Co-receptor of BMPs, Current Signal Transduction Therapy 2012; 7 (2) . https://dx.doi.org/10.2174/157436212800376690
DOI https://dx.doi.org/10.2174/157436212800376690 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Cell Therapy Using Bone Marrow-Derived Stem Cells/Endothelial Progenitor Cells to Accelerate Neovascularization in Healing of Experimental Ulcerative Colitis
Current Pharmaceutical Design Nicotine Addiction and Coronary Artery Disease: Impact of Cessation Interventions
Current Pharmaceutical Design A Comprehensive Systemic Literature Review of Pericardial Decompression Syndrome: Often Unrecognized and Potentially Fatal Syndrome
Current Cardiology Reviews Toll-Like Receptors and Human Disease: Lessons from Single Nucleotide Polymorphisms
Current Genomics Myocardial Infarction. Pathological Relevance and Relationship with Coronary Risk Factors
Current Pharmaceutical Design The Two Faces of Iminoalditols: Powerful Inhibitors Trigger Glycosidase Activation
Current Enzyme Inhibition The Evolving Roles of Nuclear Cardiology
Current Cardiology Reviews Editorial [ Hot Topic: Modifying Cardiovascular Risk Factors: Novel Cardiovascular Targets for Treatment by Noninvasive Imaging Techniques (Executive Editors: Aurelio Leone and Luigi Landini) ]
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Cardiology Reviews N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brain
Current Pharmaceutical Design Endogenous Retroelements in Cellular Senescence and Related Pathogenic Processes: Promising Drug Targets in Age-Related Diseases
Current Drug Targets Susceptibility Genes in Hypertension
Current Pharmaceutical Design The Insular Cortex and Takotsubo Cardiomyopathy
Current Pharmaceutical Design Drugs Targeting the Canonical NF-κB Pathway to Treat Viral and Autoimmune Myocarditis
Current Pharmaceutical Design The Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic Diseases
Current Vascular Pharmacology Disrupting β-Amyloid Aggregation for Alzheimer Disease Treatment
Current Topics in Medicinal Chemistry Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design Sp/KLF Family and Tumor Angiogenesis in Pancreatic Cancer
Current Pharmaceutical Design MicroRNA Regulation in Cardiovascular Disease
Current Drug Targets Acute Kidney Injury in Pediatric Heart Failure
Current Cardiology Reviews